Stronger together: Birmingham research infrastructures get together to boost innovation
Working collaboratively to pool expertise and resources and leverage synergetic strengths is key to accelerate innovation
Continue reading
Tag: industry
Promising target for liver disease treatments identified
An international clinical trial involving Birmingham Professor Phil Newsome identified a promising target for patients with
Continue reading
First clinical trial evaluating glenzocimab for heart attacks approved
The University of Birmingham and Acticor Biotech announce full regulatory approval of the LIBERATE clinical study.
Continue reading
New partnership to advance research into IBD
Researchers from the University of Birmingham will work with Roche to identify new avenues for treatment
Continue reading
New partnership aims to identify new disease mechanisms and potential targets for treatment of non-alcoholic fatty liver disease
The University of Birmingham’s Centre for Liver and Gastrointestinal Research and Novo Nordisk have joined forces
Continue reading
University of Birmingham trials a new stromal cell immunotherapy for chronic liver disease
The University of Birmingham has launched a trial which could lead to a ground-breaking new way
Continue reading
Birmingham to lead ground-breaking research into patient experience of cell therapies
Birmingham health researchers, with industry partners including health technology companies Dignio and Datatrial, have been awarded
Continue reading
Encouraging findings presented for potential new Sjögren’s treatment
The results of a Phase IIa clinical trial have suggested a potential new antibody treatment for
Continue reading